The Guangzhou-based Guangdong Provincial Drug Administration in China held a work conference on 28-Sep-2025 to discuss the preparation of the province’s 15th Five-Year Plan for drug supervision. The meeting highlighted achievements from the 14th Five-Year Plan and emphasized the need for stronger leadership, in-depth research, and enhanced drug supervision capabilities to ensure high-quality outcomes aligned with international standards and safety regulations.

Key highlights include:

  • Collaborative Planning: Officials from multiple levels of the market supervision bureau attended both online and offline sessions to ensure an inclusive planning process.
  • 14th Five-Year Plan Achievements: The province’s drug supervision system successfully implemented the 'four strictest' requirements, achieving significant progress.
  • Focus for 15th Five-Year Plan: Safety risk prevention, reform implementation, and strengthening regulatory alignment with Hong Kong, Macao, and global standards.

Freyr can help pharmaceutical companies stay informed about provincial Regulatory plans in China, align strategies with evolving supervision requirements, and ensure compliance with drug safety and quality standards.

Consult Now

Source
https://mpa.gd.gov.cn/xwdt/sjdt/content/post_4783423.html/
Select Mandate HA
NMPA
Select Mandate Function
Country Regulatory Affairs